Angiomyolipoma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(48 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Angiomyolipoma}}
{{Angiomyolipoma}}
{{CMG}}''' Associate Editor-In-Chief:''' {{CZ}}, {{Faizan}}
{{CMG}}''' Associate Editor-In-Chief:''' {{CZ}}, {{Faizan}},{{Rekha}}
==Overview==
==Overview==
If left untreated, small [[Angiomyolipoma|angiomyolipomas]] and those without dilated [[Blood vessel|blood vessels]] ([[Aneurysm|aneurysms]]) cause few [[Symptom|symptoms]]. Small [[Angiomyolipoma|angiomyolipomas]] are associated with the most favorable [[prognosis]]. Common [[complications]] of [[angiomyolipoma]] include [[infection]], [[hemorrhage]], and [[shock]].
==Natural History==
==Natural History==
If left untreated small angiomyolipomas and those without dilated blood vessels (aneurysms) cause few problems, but angiomyolipomas have been known to grow as rapidly as 4 cm in one year.
* If left untreated, small [[Angiomyolipoma|angiomyolipomas]] and those without dilated [[Blood vessel|blood vessels]] ([[aneurysm]]s) cause few problems.
*[[Angiomyolipoma (patient information)|Angiomyolipomas]] grow as rapidly as 4 cm in one year so regular surveillance is necessary depending upon the size of the [[tumour]].<ref name="pmid24325283">{{cite journal| author=Ouzaid I, Autorino R, Fatica R, Herts BR, McLennan G, Remer EM et al.| title=Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. | journal=BJU Int | year= 2014 | volume= 114 | issue= 3 | pages= 412-7 | pmid=24325283 | doi=10.1111/bju.12604 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24325283  }}</ref><ref name="pmid8230504">{{cite journal| author=Steiner MS, Goldman SM, Fishman EK, Marshall FF| title=The natural history of renal angiomyolipoma. | journal=J Urol | year= 1993 | volume= 150 | issue= 6 | pages= 1782-6 | pmid=8230504 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8230504  }}</ref>
**[[Angiomyolipoma]], less than 2cm, surveillance every 3-4 years by renal [[ultrasound]].
**[[Angiomyolipoma]] 2-4 cm, annual renal [[ultrasound]] recommended.
**[[Angiomyolipoma]] more than 4 cm, and of [[Epithelioid]] variant, renal [[ultrasound]] every 6 months initially and annual thereafter once stabilized, in case if it is not resected.
**[[Angiomyolipoma]] with high risk of [[malignant]] transformation, should undergo whole body [[Computed tomography|CT]]/[[Magnetic resonance imaging|MRI]], 6 months post [[resection]] and then yearly for at least 5 years.
 
* It has been observed in some studies that the female sex [[Hormone|hormones]] has positive impact on the size of the [[angiomyolipoma]].
* There has been increased growth and [[hemorrhagic]] [[complications]] seen during the [[pregnancy]] as well as after treatment with [[exogenous]] [[hormonal]] therapy.<ref name="pmid17018483">{{cite journal| author=Gould Rothberg BE, Grooms MC, Dharnidharka VR| title=Rapid growth of a kidney angiomyolipoma after initiation of oral contraceptive therapy. | journal=Obstet Gynecol | year= 2006 | volume= 108 | issue= 3 Pt 2 | pages= 734-6 | pmid=17018483 | doi=10.1097/01.AOG.0000188062.13749.ef | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17018483  }}</ref><ref name="pmid4082575">{{cite journal| author=Lewis EL, Palmer JM| title=Renal angiomyolipoma and massive retroperitoneal hemorrhage during pregnancy. | journal=West J Med | year= 1985 | volume= 143 | issue= 5 | pages= 675-6 | pmid=4082575 | doi= | pmc=1306454 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4082575  }}</ref><ref name="pmid21876331">{{cite journal| author=Zapardiel I, Delafuente-Valero J, Bajo-Arenas JM| title=Renal angiomyolipoma during pregnancy: review of the literature. | journal=Gynecol Obstet Invest | year= 2011 | volume= 72 | issue= 4 | pages= 217-9 | pmid=21876331 | doi=10.1159/000329328 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21876331  }}</ref><ref name="pmid16996772">{{cite journal| author=Raft J, Lalot JM, Meistelman C, Longrois D| title=[Renal angiomyolipoma rupture during pregnancy]. | journal=Gynecol Obstet Fertil | year= 2006 | volume= 34 | issue= 10 | pages= 917-9 | pmid=16996772 | doi=10.1016/j.gyobfe.2006.02.021 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16996772  }}</ref><ref name="pmid2184818">{{cite journal| author=Vandenesch F, Surgot M, Bornstein N, Paucod JC, Marmet D, Isoard P et al.| title=Relationship between free amoeba and Legionella: studies in vitro and in vivo. | journal=Zentralbl Bakteriol | year= 1990 | volume= 272 | issue= 3 | pages= 265-75 | pmid=2184818 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2184818  }}</ref>
* Due to increased rate of growth of [[angiomyolipoma]] and increased risk of its [[rupture]], it is advised to use [[estrogen]] carefully in these patients, and frequent imaging surveillance every six months initially and annual thereafter, once established, is recommended.
 
==Complications==
* Common [[complications]] of [[angiomyolipoma]] include:<ref name="pmid20410812">{{cite journal| author=Brimo F, Robinson B, Guo C, Zhou M, Latour M, Epstein JI| title=Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. | journal=Am J Surg Pathol | year= 2010 | volume= 34 | issue= 5 | pages= 715-22 | pmid=20410812 | doi=10.1097/PAS.0b013e3181d90370 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20410812  }}</ref>
**[[Infection]]s
**[[Urinary obstruction]]
**End stage [[Renal insufficiency|renal failure]], in case of bilateral [[angiomyolipoma]]
**[[Intestinal obstruction]]
**[[Shock]]
**[[Hemorrhage]]
**Rarely, it can transform into [[malignant]] [[angiomyolipoma]], especially if related to [[Tuberous sclerosis|Tuberous Sclerosis]]
 
==Prognosis==
==Prognosis==
An angiomyolipoma larger than 5 cm and those containing an aneurysm pose a significant risk of rupture, which is a medical emergency as it is potentially life-threatening. One population study found the cumulative risk of haemorrhage to be 10% in males and 20% in females.
* Small [[Angiomyolipoma|angiomyolipomas]] are associated with the most favorable [[prognosis]]. An [[angiomyolipoma]] larger than 5 cm and those containing an [[aneurysm]] pose a significant risk of [[rupture]], which is a [[medical emergency]] as it is potentially life-threatening. Cumulative risk of [[hemorrhage]] is estimated to be:<ref name="pmid26165440">{{cite journal| author=Eijkemans MJ, van der Wal W, Reijnders LJ, Roes KC, van Waalwijk van Doorn-Khosrovani SB, Pelletier C et al.| title=Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands. | journal=Am J Kidney Dis | year= 2015 | volume= 66 | issue= 4 | pages= 638-45 | pmid=26165440 | doi=10.1053/j.ajkd.2015.05.016 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26165440  }}</ref>
==Complications==
**10% among males
Complications include
**20% among females
*[[Infection]]
* [[Hematuria]]
* [[Flank pain]]
* [[Shock]] as a result of spontaneous [[hemorrhage]]


==References==
==References==
Line 21: Line 39:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Vascular medicine]]

Latest revision as of 16:08, 7 November 2019

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma natural history, complications and prognosis

CDC on Angiomyolipoma natural history, complications and prognosis

Angiomyolipoma natural history, complications and prognosis in the news

Blogs on Angiomyolipoma natural history, complications and prognosis

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Faizan Sheraz, M.D. [3],Rekha, M.D.

Overview

If left untreated, small angiomyolipomas and those without dilated blood vessels (aneurysms) cause few symptoms. Small angiomyolipomas are associated with the most favorable prognosis. Common complications of angiomyolipoma include infection, hemorrhage, and shock.

Natural History

Complications

Prognosis

References

  1. Ouzaid I, Autorino R, Fatica R, Herts BR, McLennan G, Remer EM; et al. (2014). "Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention". BJU Int. 114 (3): 412–7. doi:10.1111/bju.12604. PMID 24325283.
  2. Steiner MS, Goldman SM, Fishman EK, Marshall FF (1993). "The natural history of renal angiomyolipoma". J Urol. 150 (6): 1782–6. PMID 8230504.
  3. Gould Rothberg BE, Grooms MC, Dharnidharka VR (2006). "Rapid growth of a kidney angiomyolipoma after initiation of oral contraceptive therapy". Obstet Gynecol. 108 (3 Pt 2): 734–6. doi:10.1097/01.AOG.0000188062.13749.ef. PMID 17018483.
  4. Lewis EL, Palmer JM (1985). "Renal angiomyolipoma and massive retroperitoneal hemorrhage during pregnancy". West J Med. 143 (5): 675–6. PMC 1306454. PMID 4082575.
  5. Zapardiel I, Delafuente-Valero J, Bajo-Arenas JM (2011). "Renal angiomyolipoma during pregnancy: review of the literature". Gynecol Obstet Invest. 72 (4): 217–9. doi:10.1159/000329328. PMID 21876331.
  6. Raft J, Lalot JM, Meistelman C, Longrois D (2006). "[Renal angiomyolipoma rupture during pregnancy]". Gynecol Obstet Fertil. 34 (10): 917–9. doi:10.1016/j.gyobfe.2006.02.021. PMID 16996772.
  7. Vandenesch F, Surgot M, Bornstein N, Paucod JC, Marmet D, Isoard P; et al. (1990). "Relationship between free amoeba and Legionella: studies in vitro and in vivo". Zentralbl Bakteriol. 272 (3): 265–75. PMID 2184818.
  8. Brimo F, Robinson B, Guo C, Zhou M, Latour M, Epstein JI (2010). "Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy". Am J Surg Pathol. 34 (5): 715–22. doi:10.1097/PAS.0b013e3181d90370. PMID 20410812.
  9. Eijkemans MJ, van der Wal W, Reijnders LJ, Roes KC, van Waalwijk van Doorn-Khosrovani SB, Pelletier C; et al. (2015). "Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands". Am J Kidney Dis. 66 (4): 638–45. doi:10.1053/j.ajkd.2015.05.016. PMID 26165440.

Template:WikiDoc Sources